Install
A stock market site by Business Insider with real-time data, custom charts and breaking news. Get the latest on stocks, commodities, currencies, funds, rates, ETFs, and more.
- 904articles · 30d
- 10+ hour agolatest article
- Aug 15, 2026earliest in window
- 88%with images
- 307avg words
- tmt newswire 339
- business 336
- technology 316
- artificial intelligence 292
- globenewswire 270
- ai 170
- bitcoin 133
- local news 132
- cryptocurrency 129
- business news 125
- automotive 121
- blockchain 120
- software 115
- big data 105
- lifestyle 101
- markets 84
- corporate banking 81
- health 81
- community 79
- innovation 74
- Economy, Business & Finance 709
- Finance & Business 540
- Finance 197
- News 136
- Business & Industrial 119
- Health & Wellness 63
- Medical 50
- Transportation 49
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
BayCare Generates $13 Billion in Economic Impact Annually for Florida
5+ day, 12+ hour ago (477+ words) BayCare 16 hospitals provide the largest portion of economic impact at $8.7 billion. BayCare Medical Group, the region’s largest multispecialty physician group, grew by 154% to $1.9 billion. BayCare Generates $13 Billion in Economic Impact Annually for Florida CLEARWATER, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- BayCare’s commitment…...
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
4+ day, 14+ hour ago (398+ words) Preclinical results demonstrate pelareorep activity is maintained in the presence of RAS inhibitionFindings support further evaluation of pelareor... Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer Preclinical results demonstrate pelareorep activity is maintained…...
Hexiris Ophthalmics to Present First-in-Human OBi Glaucoma Data at Five Fall Meetings, Beginning with the Ophthalmology Futures Forum in London
4+ day, 20+ hour ago (430+ words) Hexiris was founded by surgeons Dr. Houfar Sekhavat and Dr. Nir Shoham-Hazon after humanitarian missions in Gabon, Mozambique and Mexico, where they saw the same reality in every clinic: effective treatments for glaucoma exist, but far too many patients cannot…...
Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes
5+ day, 17+ hour ago (533+ words) Financing will support lead program ALG-115 through IND-enabling studies toward clinical evaluation in lung transplantationRound was led by NBank... Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes - Financing will support…...
Rad Source Technologies Introduces Sterile Insect Farms⢠| Markets Insider
4+ day, 27+ min ago (382+ words) Rad Source Technologies Introduces Sterile Insect Farms™ markets.businessinsider.com Rad Source Technologies Introduces Sterile Insect Farms™ BUFORD, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies, a leading innovator in X-ray solutions for life sciences, is proud to announce Sterile Insect…...
The BodyMind Workout Announces Dr. Desi Bartlett’s New Perimenopause and Midlife Programming Partnership With Glo
3+ day, 21+ hour ago (298+ words) Honolulu, HI, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The BodyMind Workout®, founder Dr. Desi Bartlett, Ed.D., today announced a new partnership with Glo, the premier online destination for yoga, meditation, and fitness, to launch new programming for women navigating perimenopause and midlife....
Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026
3+ day, 23+ hour ago (261+ words) Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of Schedule II and Schedule IV pain drugs, further differentiating its dual NOP/MOP mechanism from drugs like oxycodone. The Phase 3 ALLEVIATE studies met…...
Trethera Congratulates Board Director Dr. Timothy R. Donahue on Appointment to Senior Leadership Roles at Weill Cornell Medicine and NewYork-Presbyterian
4+ day, 22+ hour ago (575+ words) markets.businessinsider.com Trethera Congratulates Board Director Dr. Timothy R. Donahue on Appointment to Senior Leadership Roles at Weill Cornell Medicine and NewYork-Presbyterian LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer and…...
Beyond the Chatbot: How JD Health Is Bringing AI Into Doctors’ Everyday Work
5+ day, 3+ hour ago (774+ words) September 9, 2026 -- A doctor reviewing a complex case may need to search through medical literature, check the latest clinical guidelines, assess drug interactions, interpret test results and bring together years of patient information, often under significant time pressure. This is where…...
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026 | Markets Insider
5+ day, 4+ hour ago (496+ words) RadNet to Host Free Prostate Cancer Webinar on September 19, 2026 markets.businessinsider.com RadNet to Host Free Prostate Cancer Webinar on September 19, 2026 LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic…...